HK1245261A1 - Heterocyclic compound used as fgfr inhibitor - Google Patents

Heterocyclic compound used as fgfr inhibitor

Info

Publication number
HK1245261A1
HK1245261A1 HK18104644.2A HK18104644A HK1245261A1 HK 1245261 A1 HK1245261 A1 HK 1245261A1 HK 18104644 A HK18104644 A HK 18104644A HK 1245261 A1 HK1245261 A1 HK 1245261A1
Authority
HK
Hong Kong
Prior art keywords
compound used
heterocyclic compound
fgfr inhibitor
fgfr
inhibitor
Prior art date
Application number
HK18104644.2A
Other languages
Chinese (zh)
Inventor
孔祥龍
鄭之祥
周超
Original Assignee
南京天印健華醫藥科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南京天印健華醫藥科技有限公司 filed Critical 南京天印健華醫藥科技有限公司
Priority to HK18104644.2A priority Critical patent/HK1245261A1/en
Publication of HK1245261A1 publication Critical patent/HK1245261A1/en

Links

HK18104644.2A 2018-04-10 2018-04-10 Heterocyclic compound used as fgfr inhibitor HK1245261A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK18104644.2A HK1245261A1 (en) 2018-04-10 2018-04-10 Heterocyclic compound used as fgfr inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK18104644.2A HK1245261A1 (en) 2018-04-10 2018-04-10 Heterocyclic compound used as fgfr inhibitor

Publications (1)

Publication Number Publication Date
HK1245261A1 true HK1245261A1 (en) 2018-08-24

Family

ID=71142866

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18104644.2A HK1245261A1 (en) 2018-04-10 2018-04-10 Heterocyclic compound used as fgfr inhibitor

Country Status (1)

Country Link
HK (1) HK1245261A1 (en)

Similar Documents

Publication Publication Date Title
IL276509A (en) Heterocyclic compounds as kinase inhibitors
IL282535A (en) Substituted 6-azabenzimidazole compounds as hpk1 inhibitors
IL277539A (en) Heterocyclic compounds as immunomodulators
EP3498706A4 (en) Heterocyclic compound as fgfr inhibitor
SG11202010882XA (en) Salts of an fgfr inhibitor
IL274762A (en) Novel heterocyclic compounds as prmt5 inhibitors
IL290508A (en) Heterocyclic compounds as kinase inhibitors
IL280821A (en) Heterocyclic compound
SG10202013038VA (en) Heterocyclic compound used as fgfr inhibitor
EP3483158A4 (en) Heterocyclic compound serving as fgfr4 inhibitor
SG11202013016YA (en) Heterocyclic compounds as trk inhibitors
IL282659A (en) Heterocyclic compounds as bet inhibitors
IL289617A (en) Heterocyclic compounds
IL289595A (en) Heterocyclic compounds
GB201819126D0 (en) Inhibitor compounds
EP3720495A4 (en) Heterocyclic compounds as prmt5 inhibitors
ZA202104402B (en) Heterocyclic compound
IL289389A (en) Heterocyclic compounds as kinase inhibitors
SG11202009356RA (en) Heterocyclic compound
HK1245261A1 (en) Heterocyclic compound used as fgfr inhibitor
IL277340A (en) Heterocyclic compound
HK1252918A1 (en) Heterocyclic compounds as erk inhibitors
GB201819136D0 (en) Inhibitor compounds
GB201806131D0 (en) Inhibitor compounds
GB201806130D0 (en) Inhibitor compounds